518 related articles for article (PubMed ID: 15195209)
21. Epstein-Barr virus (EBV) and Hodgkin's disease in children: incidence of EBV latent membrane protein in malignant cells.
Weinreb M; Day PJ; Murray PG; Raafat F; Crocker J; Parkes SE; Coad NA; Jones JT; Mann JR
J Pathol; 1992 Dec; 168(4):365-9. PubMed ID: 1336543
[TBL] [Abstract][Full Text] [Related]
22. Expression of Epstein-Barr virus in patients with Hodgkin's disease in Taiwan.
Liu SM; Chow KC; Chiu CF; Tzeng CH
Cancer; 1998 Jul; 83(2):367-71. PubMed ID: 9669821
[TBL] [Abstract][Full Text] [Related]
23. Human herpesvirus 6 and Epstein-Barr virus in Hodgkin's disease: a controlled study by polymerase chain reaction and in situ hybridization.
Valente G; Secchiero P; Lusso P; Abete MC; Jemma C; Reato G; Kerim S; Gallo RC; Palestro G
Am J Pathol; 1996 Nov; 149(5):1501-10. PubMed ID: 8909240
[TBL] [Abstract][Full Text] [Related]
24. Expression of the latent membrane protein of Epstein-Barr virus in Hodgkin's disease. Age and subtype distribution in Polish patients.
Kordek R; Jesionek-Kupnicka D; Biernat W; Woźniak L
Acta Haematol Pol; 1996; 27(1):15-20. PubMed ID: 8629438
[TBL] [Abstract][Full Text] [Related]
25. Viral involvement in Hodgkin's disease.
Jarrett RF
Int J Cell Cloning; 1992 Nov; 10(6):315-22. PubMed ID: 1334112
[TBL] [Abstract][Full Text] [Related]
26. [Association of Epstein-Barr virus and Hodgkin's disease: comparison between Algerian and French patients].
Belkaid MI; Zerhouni F; Beljord K; Brière J; Assouak W; Djebbara Z; Andrieu JM; Colonna P
Bull Cancer; 1995; 82(5):357-63. PubMed ID: 7626843
[TBL] [Abstract][Full Text] [Related]
27. Frequent expression of Epstein-Barr virus latent membrane protein-1 in tumour cells of Hodgkin's disease in HIV-positive patients.
Audouin J; Diebold J; Pallesen G
J Pathol; 1992 Aug; 167(4):381-4. PubMed ID: 1328576
[TBL] [Abstract][Full Text] [Related]
28. [Epstein-Barr virus in Hodgkin's disease: the example of central Tunisia].
Korbi S; Trimeche M; Sriha B; Yacoubi MT; Hmissa S; Mokni M; Delvenne P; Boniver J; Rammeh S
Ann Pathol; 2002 Apr; 22(2):96-101. PubMed ID: 12124490
[TBL] [Abstract][Full Text] [Related]
29. Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin's lymphoma.
Claviez A; Tiemann M; Lüders H; Krams M; Parwaresch R; Schellong G; Dörffel W
J Clin Oncol; 2005 Jun; 23(18):4048-56. PubMed ID: 15961758
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical detection of Epstein-Barr virus-encoded latent membrane protein in Reed-Sternberg cells and variants of Hodgkin's disease.
Pinkus GS; Lones M; Shintaku IP; Said JW
Mod Pathol; 1994 May; 7(4):454-61. PubMed ID: 7520586
[TBL] [Abstract][Full Text] [Related]
31. Detection of EBV mRNA in nodular sclerosis type of Hodgkin's disease using in situ hybridization with EBER 1 and EBER 2 probes with regard to the immunophenotype of Reed-Sternberg cells.
Jesionek-Kupnicka D; Berger F; Jubin B; Bryon PA; Woźniak L
Pol J Pathol; 1995; 46(2):71-5. PubMed ID: 7640949
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data.
Glaser SL; Lin RJ; Stewart SL; Ambinder RF; Jarrett RF; Brousset P; Pallesen G; Gulley ML; Khan G; O'Grady J; Hummel M; Preciado MV; Knecht H; Chan JK; Claviez A
Int J Cancer; 1997 Feb; 70(4):375-82. PubMed ID: 9033642
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus and other candidate viruses in the pathogenesis of Hodgkin's disease.
Jarrett RF; MacKenzie J
Semin Hematol; 1999 Jul; 36(3):260-9. PubMed ID: 10462326
[TBL] [Abstract][Full Text] [Related]
34. Expression of bcl-2 protein and Epstein-Barr virus latent membrane protein in Hodgkin's disease.
Kordek R; Biernat W; Kupnicka D; Woźniak L
Pol J Pathol; 1994; 45(4):279-81. PubMed ID: 7697330
[TBL] [Abstract][Full Text] [Related]
35. Detection of Epstein-Barr virus in Hodgkin's lymphoma (patients in the Czech Republic).
Macák J; Habanec B; Fabián P
Neoplasma; 2000; 47(3):156-61. PubMed ID: 11043838
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus expression in Hodgkin's disease in relation to patient characteristics, serum factors and blood lymphocyte function.
Axdorph U; Porwit-MacDonald A; Sjöberg J; Grimfors G; Ekman M; Wang W; Biberfeld P; Björkholm M
Br J Cancer; 1999 Dec; 81(7):1182-7. PubMed ID: 10584880
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study.
Keegan TH; Glaser SL; Clarke CA; Gulley ML; Craig FE; Digiuseppe JA; Dorfman RF; Mann RB; Ambinder RF
J Clin Oncol; 2005 Oct; 23(30):7604-13. PubMed ID: 16186595
[TBL] [Abstract][Full Text] [Related]
38. Detection and genotyping of Epstein-Barr virus by polymerase chain reaction in tissues obtained from cases with Hodgkin's disease in Turkey.
Durmaz R; Aydin A; Köroglu M; Aker H; Ozercan IH; Atik E; Arici S
Acta Virol; 1998 Dec; 42(6):375-81. PubMed ID: 10358743
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical demonstration of the Epstein-Barr virus-encoded latent membrane protein in paraffin sections of Hodgkin's disease.
Murray PG; Young LS; Rowe M; Crocker J
J Pathol; 1992 Jan; 166(1):1-5. PubMed ID: 1311374
[TBL] [Abstract][Full Text] [Related]
40. The effect of Epstein-Barr virus status on clinical outcome in Hodgkin's lymphoma.
Kwon JM; Park YH; Kang JH; Kim K; Ko YH; Ryoo BY; Lee SS; Lee SI; Koo HH; Kim WS
Ann Hematol; 2006 Jul; 85(7):463-8. PubMed ID: 16534596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
